HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM

HAEMOPHILUS INFLUENZAE TYPE B ANTISERUM is an FDA 510(k)-cleared medical device (K820192) manufactured by Hyland Therapeutic Div., Travenol Laboratories. This device is classified under the Microbiology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on March 10, 1982. Regulation: 8.